Accumulation of quinolinic acid with neuroinflammation: Does it mean excitotoxicity?

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 147-154

  Obrenovitch, Tiho P ^a   Urenjak, Jutta ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE; LACTIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POTASSIUM ION; QUINOLINIC ACID;

ANESTHESIOLOGICAL TECHNIQUES; ANIMAL TISSUE; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; ELECTRODE; ELECTROPHYSIOLOGY; GERBIL; IMMUNOREACTIVITY; MALE; MEMBRANE DEPOLARIZATION; MICRODIALYSIS; MOLECULAR PROBE; NEURITIS; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ANIMALIA; GERBILLINAE;

EID: 1042279509     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_17     Document Type: Conference Paper

References (34)

1. M.P. Heyes, The kynurenine pathway and neurologic disease. Therapeutic strategies, Adv. Exp. Med. Biol. 398, 125-129 (1996).
2. G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection, J. Neurochem. 78, 842-853 (2001).
3. D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Köhler, A.M. Cesura, Regulation of the kynurenine metabolic pathway by interferon-γ in murine cloned macrophages and microglial cells, J. Neurochem. 66, 996-1004 (1996).
4. G.J. Guillemin, S.J. Kerr, L.A. Pemberton, D.G. Smith, G.A. Smythe, P.J. Armati, J. Croitoru, B.J. Brew, 1FN-β1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment, J. Interferon Cytokine Res. 21, 1097-1101 (2001).
5. R. Schwarcz, W.O. Jr. Whetsell, R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219, 316-318 (1983).
6. M. Levivier, S. Przedborski, Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment, Neurol. Res. 20, 46-56 (1998).
7. M.C. Curras, R. Dingledine, Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl- isoxazoleproprionate receptors, Mol. Pharmacol. 41, 520-526 (1992).
8. T.P. Obrenovitch, D.A. Richards, G.S. Sama, L. Symon, Combined intracerebral microdialysis and electrophysiological recording: Methodology and applications, J. Neurosci. Meth. 47, 139-145 (1993).
9. T.P. Obrenovitch, J. Urenjak, E. Zilkha, Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo, Br. J. Pharmacol. 113, 1295-1302 (1994).
10. T.P. Obrenovitch, J. Urenjak, E. Zilkha. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo, Br. J. Pharmacol. 113, 1295-1302 (1994).
11. R. Exley, E. Zilkha, J. Urenjak, T.P. Obrenovitch, Continuous monitoring of changes in brain extracellular lactate using microdialysis coupled to enzyme-amperometric analysis, Br. J. Pharmacol. 131(Suppl.), 219 (2000).
12. K.E. Beagles, P.F. Morrison, M.P. Heyes, Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis, J. Neurochem. 70, 281-291 (1998).
13. M. Minervini, A. Atlante, S. Gagliardi, M.T. Ciotti, E. Marra, P. Calissano, Glutamate stimulates 2-deoxyglucose uptake in rat cerebellar granule cells, Brain Res. 768, 57-62 (1997).
14. Y.M. Bordelon, M.-F. Chesselet, M. Erecinska, I.A. Silver, Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo, Neuroscience 83, 459-469 (1998).
15. M. Demestre, M. Boutelle, M. Fillenz, Stimulated release of lactate in freely moving rats is dependent on the uptake of glutamate, J. Physiol. 499, 825-832 (1997).
16. A.E. Fray, R.J. Forsyth, M.G. Boutelle, M. Fillenz, The mechanisms controlling physiologically stimulated changes in rat brain glucose and lactate: a microdialysis study, J. Physiol. 496, 49-57 (1996).
17. T.P. Obrenovitch TP, E. Zilkha, Microdialysis coupled to online enzymatic assays, Methods 23, 63-71 (2001).
18. T.P. Obrenovitch, E. Zilkha, Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D- aspartate receptor complex, Br. J. Pharmacol. 117, 931-937 (1996).
19. F.S. Menniti, M.J. Pagnozzi, P. Butler, B.L. Chenard, S.S. Jaw-Tsai, W. Frost, White CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents, Neuropharmacology 39, 1147-1155 (2000).
20. T.P. Obrenovitch, E. Zilkha, J. Urenja, Evidence against high extracellular glutamate promoting the elicitation of spreading depression by potassium, J. Cereb. Blood Flow Metab. 16, 923-931 (1996).
21. W.O. Whetsell, R. Schwarcz, Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system, Neurosci. Lett. 97, 271-275 (1989).
22. S.J. Kerr, P.J. Armati, G.J. Guillemin, B.J. Brew, Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS, 12, 3555-363 (1998).
23. R. Balazs, N. Hack, O.S. Jorgensen, C.W. Cotman, N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological considerations, Neurosci. Lett. 101, 242-246 (1989).
24. D.M. Chuang, X.M. Gao, S.M. Paul, N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells, Mol. Pharmacol. 42, 210-216 (1992).
25. N.J. Pantazis, O.P. Dohrman, J. Luo, J.D. Thomas, C.R. Goodlett, J.R. West, NMDA prevents alcohol-induced neuronal cell death of cerebellar granule cells in culture, Alcohol Clin. Exp. Res. 19, 846-853 (1995).
26. A.M. Marini, Y. Ueda, C.H. June, Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons, Intracellular calcium responses, Ann. N.Y. Acad. Sci. 890, 421-437 (1999).
27. A.M. Marini, S.J. Rabin, R.H. Lipsky, I. Mocchetti, Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate, J. Biol. Chem. 273, 29394-29399 (1998).
28. Y. Sei, L. Fossom, G. Goping, P. Skolnick, A.S. Basile, Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis, Neurosci. Lett. 241, 180-184 (1998).
29. Z.H. Qin, R.W. Chen, Y. Wang, M. Nakai, D.M. Chuang, T.N. Chase, Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum, J. Neurosci. 19, 4023-4033 (1999).
30. W.M. Behan, M. McDonald, L.G. Darlington, T.W. Stone, Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl, Br. J. Pharmacol. 128, 1754-1760 (1999).
31. T.W. Stone. Endogenous neurotoxins from tryptophan, Toxicon. 39, 61-73 (2001).
32. H. Lehnert, R.J. Wurtman, Amino acid control of neurotransmitter synthesis and release: physiological and clinical implications, Psychother. Psychosom. 60, 18-32 (1993).
33. F.A. Moreno, C. McGavin, T.P. Malan, A.J. Gelenberg, G.R. Heninger, A.A. Mathe, P.L. Delgado, Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling technique, Int. J. Neuropsychopharmacol. 3, 277-283 (2000).
34. C. Bell, J. Abrams, D. Nutt, Tryptophan depletion and its implications for psychiatry, Br. J. Psychiatry 178, 399-405 (2001). 154